Source map — The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| reuters.com | news | 60% |
| Bloomberg.com | news | 60% |
| WSJ | news | 60% |
| Yahoo Finance | news | 60% |
| fiercebiotech.com | news | 60% |
| The New York Times | news | 60% |
| simple.wikipedia.org | news | 50% |
| biotechmorning.com | news | 50% |
| www.webmd.com | news | 50% |
| my.clevelandclinic.org | news | 50% |
| en.wikipedia.org | news | 50% |
| ecgwaves.com | news | 50% |
| thecodon.substack.com | news | 50% |
| www.healthline.com | news | 50% |
| veevohealth.com | news | 50% |
| usinsider.com | news | 50% |
| www.heart.co.uk | news | 50% |
| www.medicalnewstoday.com | news | 50% |
| www.medscape.com | news | 50% |
| www.clinicaltrialvanguard.com | news | 50% |
| www.menshb.com | news | 50% |
| hillarylinmd.com | news | 50% |
| live.euronext.com | news | 50% |
| www.youtube.com | news | 50% |
| www.pharmacytimes.com | news | 50% |
| trial.medpath.com | news | 50% |
| www.trialticker.com | news | 50% |
| allsci.com | news | 50% |
| en.ilsole24ore.com | news | 50% |
| www.yahoo.com | news | 50% |
| finance.yahoo.com | news | 50% |
| www.marketscreener.com | news | 50% |
| www.globalbankingandfinance.com | news | 50% |
| blockonomi.com | news | 50% |
| european-biotechnology.com | news | 50% |
| www.briefs.co | news | 50% |
| finance.biggo.com | news | 50% |
| english.gujaratsamachar.com | news | 50% |
| pauldthompsonmd.substack.com | news | 50% |
| www.capitalbrief.com | news | 50% |
| medicalxpress.com | news | 50% |
| www.thecardiologyadvisor.com | news | 50% |
| www.ad-hoc-news.de | news | 50% |
| pharmaphorum.com | news | 50% |
| nexi.fund | news | 50% |
| catalystalert.io | news | 50% |
| www.el-fondo.com | news | 50% |
| imedic.health | news | 50% |